 
The Patent Office Journal 31/08/2012 
13712
(12) PATENT APPLICATION PUBLICATION (21) Application No.695/MUMNP/2012 A 
(19) INDIA  
(22) Date of filing of Application :19/03/2012 (43) Publication Date : 31/08/2012 
  
(54) Title of the invention : BLADDER CANCER SPECIFIC LIGAND PEPTIDES  
  
(51) International classification  :C07K7/06  
(31) Priority Document No  :61/245,492  
(32) Priority Date  :24/09/2009 
(33) Name of priority country  :U.S.A. 
(86) International Application No 
        Filing Date 
:PCT/US2010/050037
:23/09/2010 
(87) International Publication No  :WO/2011/038142  
(61) Patent of Addition to Application 
Number  
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)THE REGENTS OF THE UNIVERSITY OF 
CALIFORNIA 
      Address of Applicant :1111 FRANKLIN STREET,12TH 
FLOOR OAKLAND,CALIFORNIA 94607-5200 UNITED 
STATES OF AMERICA. 
(72)Name of Inventor : 
   1)PAN,CHONG-XIAN 
   2)ZHANG , HONGYONG 
   3)LAM,KIT S. 
   4)AINA , OLULANU H. 
   5)N/A  
(57) Abstract : 
The present invention is directed to bladder cancer specific ligand peptides, comprising the amino acid sequence X1DGRX5GF (SEQ 
ID NO:1), and methods of their use, e.g., for imaging detection for diagnosis of bladder, tumor localization to guide transurethral 
resection of bladder cancer, imaging detection of bladder cancer for follow-up after the initial treatment that can replace or 
complement costly cystoscopy, imaging detection of metastatic bladder cancer, and targeted therapy for superficial and metastatic 
bladder cancer. 
  
  
No. of Pages : 81 No. of Claims : 22 
